PL3068428T3 - Sposoby i kompozycje wariantów aneksyny ii - Google Patents

Sposoby i kompozycje wariantów aneksyny ii

Info

Publication number: PL3068428T3
Authority: PL; Poland
Prior art keywords: annexin; methods; variant compositions; variant; compositions
Prior art date: 2013-11-13

Application number

PL14812331.8T

Other languages

English (en)

Inventor

John R. Ohlfest

Michael R. Olin

Original Assignee

Regents Of The University Of Minnesota

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-11-13

Filing date

2014-11-13

Publication date

2023-03-13

2014-11-13 Application filed by Regents Of The University Of Minnesota filed Critical Regents Of The University Of Minnesota

2023-03-13 Publication of PL3068428T3 publication Critical patent/PL3068428T3/pl

Links

102000000412 Annexin Human genes 0.000 title 1
108050008874 Annexin Proteins 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/46449—Melanoma antigens
- A61K39/464492—Glycoprotein 100 [Gp100]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Cell Biology (AREA)
Mycology (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Hematology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Marine Sciences & Fisheries (AREA)
Gastroenterology & Hepatology (AREA)
Developmental Biology & Embryology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL14812331.8T 2013-11-13 2014-11-13 Sposoby i kompozycje wariantów aneksyny ii PL3068428T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361903628P	2013-11-13	2013-11-13
PCT/US2014/065390 WO2015073632A1 (en)	2013-11-13	2014-11-13	Annexin ii variant compositions and methods

Publications (1)

Publication Number	Publication Date
PL3068428T3 true PL3068428T3 (pl)	2023-03-13

Family

ID=52101577

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL14812331.8T PL3068428T3 (pl)	2013-11-13	2014-11-13	Sposoby i kompozycje wariantów aneksyny ii

Country Status (9)

Country	Link
US (1)	US10206986B2 (pl)
EP (1)	EP3068428B1 (pl)
AU (1)	AU2014348645B2 (pl)
CA (1)	CA2930567C (pl)
DK (1)	DK3068428T3 (pl)
ES (1)	ES2928331T3 (pl)
HU (1)	HUE060293T2 (pl)
PL (1)	PL3068428T3 (pl)
WO (1)	WO2015073632A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2016146143A1 (en) *	2015-03-16	2016-09-22	Amal Therapeutics Sa	Cell penetrating peptides and complexes comprising the same
DK3468621T3 (da) *	2016-06-10	2022-12-05	Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts	Kernedomæne af annexiner og anvendelser deraf i antigenindgivelse og vaccination
MX2019002968A (es) *	2016-09-21	2019-10-15	Amal Therapeutics Sa	Un complejo novedoso que comprende un peptido penetrante de celulas, una carga y un agonista de peptido de tlr para tratamiento de cancer colorrectal.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7262167B2 (en)	1995-11-06	2007-08-28	Exibona Ltd.	Drug, in particular for modulating the immunological response for the control of viruses, tumors, bacteria and parasites
US6645465B2 (en)	1999-08-06	2003-11-11	Michigan, University Of The Regents	Annexin proteins and autoantibodies as serum markers for cancer
ES2272537T3 (es) *	2000-09-01	2007-05-01	Philadelphia, Health And Education Corporation	Metodos y composiciones para inhibir la angiogenesis.
DE10225144A1 (de)	2002-05-29	2003-12-18	Immatics Biotechnologies Gmbh	An MHC-Moleküle bindende Tumor-assoziierte Peptide
US7695725B2 (en)	2003-02-06	2010-04-13	Aduro Biotech	Modified free-living microbes, vaccine compositions and methods of use thereof
EP3115063A3 (en)	2008-12-03	2017-04-19	The John Hopkins University	Galectin-3 and annexin-a2 as immunological target
KR101121198B1 (ko) *	2009-05-20	2012-03-23	(주)노바셀테크놀로지	태반에서 추출된 펩타이드 혼합물, 그의 제조 방법 및 용도
US9555074B2 (en)	2010-10-08	2017-01-31	Regents Of The University Of Minnesota	Annexin II compositions

2014
- 2014-11-13 US US15/036,115 patent/US10206986B2/en active Active
- 2014-11-13 PL PL14812331.8T patent/PL3068428T3/pl unknown
- 2014-11-13 EP EP14812331.8A patent/EP3068428B1/en active Active
- 2014-11-13 WO PCT/US2014/065390 patent/WO2015073632A1/en active Application Filing
- 2014-11-13 DK DK14812331.8T patent/DK3068428T3/da active
- 2014-11-13 CA CA2930567A patent/CA2930567C/en active Active
- 2014-11-13 ES ES14812331T patent/ES2928331T3/es active Active
- 2014-11-13 AU AU2014348645A patent/AU2014348645B2/en active Active
- 2014-11-13 HU HUE14812331A patent/HUE060293T2/hu unknown

Also Published As

Publication number	Publication date
EP3068428A1 (en)	2016-09-21
US20160279212A1 (en)	2016-09-29
DK3068428T3 (da)	2022-10-17
HUE060293T2 (hu)	2023-02-28
CA2930567C (en)	2023-09-26
WO2015073632A1 (en)	2015-05-21
AU2014348645B2 (en)	2019-01-24
AU2014348645A1 (en)	2016-06-02
US10206986B2 (en)	2019-02-19
CA2930567A1 (en)	2015-05-21
EP3068428B1 (en)	2022-08-17
ES2928331T3 (es)	2022-11-17

Publication	Publication Date	Title
IL273205A (en)	2020-04-30	Preparations and methods
IL289821B (en)	2022-12-01	Preparations and methods for immunotherapy
HK1218837A1 (zh)	2017-03-17	組合物和方法
HK1218560A1 (zh)	2017-02-24	組成與方法
GB2527241B (en)	2018-04-11	Compositions and methods
HK1218692A1 (zh)	2017-03-10	組合物和食物
HK1220387A1 (zh)	2017-05-05	用於免疫療法的組合物和方法
ZA201603237B (en)	2017-09-27	Pesticidal compositions and related methods
GB201308072D0 (en)	2013-06-12	Compositions and methods
IL285527A (en)	2021-09-30	Preparations and methods for immunotherapy
IL245035A0 (en)	2016-05-31	Pesticides and related methods
ZA201603227B (en)	2017-09-27	Pesticidal compositions and related methods
ZA201603229B (en)	2017-09-27	Pesticidal compositions and related methods
GB201305813D0 (en)	2013-05-15	Compositions and methods
IL276126B (en)	2022-05-01	Preparations containing l-4-chloroquinonerine and their uses
IL245034A0 (en)	2016-05-31	Pesticides and related methods
ZA201603241B (en)	2017-09-27	Pesticidal compositions and related methods
EP2964610A4 (en)	2016-11-23	VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF
PL3068428T3 (pl)	2023-03-13	Sposoby i kompozycje wariantów aneksyny ii
GB201322617D0 (en)	2014-02-05	Methods and compositions
GB201312393D0 (en)	2013-08-21	Compositions and Methods
GB201308242D0 (en)	2013-06-12	Compositions and uses thereof